or Try an Advanced Search...

    Technical Analysis for NBTX - Nanobiotix S.A.

    Grade Last Price % Change Price Change
    D 5.35 7.00% 0.35
    NBTX closed up 7.0 percent on Monday, July 1, 2024, on 80 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical NBTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Fell Below 20 DMA Bearish 7.00%
    New Downtrend Bearish 7.00%
    Wide Bands Range Expansion 7.00%
    Crossed Above 20 DMA Bullish -4.46%
    MACD Bullish Signal Line Cross Bullish -4.46%
    New Uptrend Bullish -4.46%
    Older End-of-Day Signals for NBTX ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    20 DMA Resistance about 7 hours ago
    Gap Up Partially Closed about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NBTX Chart by TradingView
    Basic chart:

    Profile

    Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

    Is NBTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
    Jun 11 Voting Rights and Shares Capital of the Company
    Jun 2 Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
    May 28 NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
    May 23 NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
    May 23 Nanobiotix S.A. (NBTX) Q1 2024 Earnings Call Transcript
    May 22 Nanobiotix reports Q1 results
    May 22 NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
    May 21 Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
    May 15 NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
    See more NBTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.0
    52 Week Low 4.14
    Average Volume 7,015
    200-Day Moving Average 6.60
    50-Day Moving Average 6.02
    20-Day Moving Average 5.34
    10-Day Moving Average 4.83
    Average True Range 0.40
    RSI (14) 47.92
    ADX 24.22
    +DI 27.51
    -DI 33.82
    Chandelier Exit (Long, 3 ATRs) 6.09
    Chandelier Exit (Short, 3 ATRs) 5.34
    Upper Bollinger Bands 6.88
    Lower Bollinger Band 3.81
    Percent B (%b) 0.5
    BandWidth 57.37
    MACD Line -0.34
    MACD Signal Line -0.41
    MACD Histogram 0.071
    Fundamentals Value
    Market Cap 252.04 Million
    Num Shares 47.1 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -2.96
    Price-to-Sales 51.51
    Price-to-Book 65.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.84
    Resistance 3 (R3) 5.80 5.59 5.76
    Resistance 2 (R2) 5.59 5.46 5.61 5.73
    Resistance 1 (R1) 5.47 5.39 5.53 5.51 5.70
    Pivot Point 5.26 5.26 5.29 5.28 5.26
    Support 1 (S1) 5.14 5.14 5.20 5.19 5.00
    Support 2 (S2) 4.93 5.06 4.96 4.97
    Support 3 (S3) 4.82 4.93 4.94
    Support 4 (S4) 4.86